⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3155628 | 0.89 | — | — | |
| SCHEMBL9097483 | 0.81 | MEN1 (0.31) | — | |
| SCHEMBL2760826 | 0.75 | — | — | |
| SCHEMBL6853828 | 0.73 | — | — | |
| SCHEMBL3755180 | 0.70 | — | — | |
| SCHEMBL9564557 | 0.67 | — | — | |
| SCHEMBL2495779 | 0.65 | — | — | |
| SCHEMBL29471028 | 0.64 | — | — | |
| SCHEMBL8435140 | 0.62 | — | — | |
| SCHEMBL30091169 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6489464-B1 | Branched oligonucleotides as pathogen-inhibitory agents | HYBRIDON, INC. | 2002-12-03 | — | — | US | disclosed |
| EP-0763050-B1 | Branched oligonucleotide as pathogen-inhibitory agents | HYBRIDON INC (US) | 2000-01-05 | — | — | EP | disclosed |
| EP-0763050-A1 | BRANCHED OLIGONUCLEOTIDES AS PATHOGEN-INHIBITORY AGENTS | HYBRIDON, Inc. (US) | 1997-03-19 | — | — | EP | disclosed |
| WO-1995032986-A1 | BRANCHED OLIGONUCLEOTIDES AS PATHOGEN-INHIBITORY AGENTS | HYBRIDON, INC. (US) | 1995-12-07 | — | — | WO | disclosed |